ABOUT N-OF-ONE
N-of-One works directly with cancer patients and their physicians in the search for the best available treatment. A team of our clinicians and scientists provides access to the latest cancer research, cutting-edge medical science, and molecular diagnostic testing. We are at the forefront of personalized medicine, a new field that uses diagnostic tests to identify biological markers driving a particular cancer. Understanding a tumor's particular biological characteristics may help to determine specific treatment for each individual patient.
N-of-One—On the Leading Edge of a Revolution in Cancer Care
THE PROBLEM: Patients want the best possible medical care, especially when they are fighting cancer. But there are obstacles:
- Cancer treatment is one of the fastest moving fields in medicine. The explosion of research is overwhelming, and it is challenging to keep current.
- Doctors don't always agree on the best way to treat particular cancers.
- Medical information travels slowly. It can take a year or more for breakthroughs to become standard practice.
- Cancer treatments are extremely expensive and often have serious side effects, particularly when they target all dividing cells including healthy ones.
- For rare and advanced cancers, the best options are often found in clinical trials, but finding the right trial to enter can be difficult.
OUR SOLUTION: Buried inside that explosion of research are key advances. Genetic studies have revealed that even tumors that arise in the same organ can be profoundly different at the molecular level. Figuring out the "molecular drivers" of a particular tumor may be the key to being able to slow or stop its growth. That realization has led to a new emphasis on treating cancer using specialized diagnostics to study a tumor in detail and then choosing treatments based on its molecular characteristics. This is personalized medicine.
HOW WE DO THIS: N-of-One harnesses this emerging science with a bold new model of cancer care. Our team works with a network of state-of-the-art diagnostic laboratories, leading-edge research institutions, and top cancer experts. Our team supplements, but does not replace, your own doctors.We can:
- Pinpoint the scientific advances that will change clinical practice as they occur.
- Give patients access to cutting-edge information about their disease.
- Determine the optimal testing and treatments that are currently available.
- Provide access to the highest quality and most comprehensive diagnostic tumor testing.
- Facilitate analysis of each patient's tumor and, based on this information, identify advanced treatment strategies.
N-of-One—Making It Personal
Our company name—N-of-One—reflects our approach to personalized cancer treatment. In a typical clinical trial, the "N," or number of patients enrolled, is as large as possible in order to identify what works in the average patient. But the more we know about cancer, the less sense it makes to treat patients as if they were "average." For example, researchers estimate that there may be 20 distinct types of breast cancer alone—each one of which will respond best to a different type of therapy. Subtypes of other cancers are also emerging.
With us, each patient is not "average"; rather, each patient is the only "N". Our job begins with understanding as much as possible about each patient's cancer at the most fundamental level—it's molecular biology. Based on sophisticated genetic and molecular analyses of a patient's tumor, N-of-One brings to light information that helps patients and their physicians make truly informed decisions.
N-of-One—Independent and Unbiased
We do charge for our services. However, to serve cancer patients and their medical team with integrity, we do not profit from any laboratory testing, entry into clinical trials, or referrals to cancer centers or members of our expert network.
